Risk versus risk: a review of benzodiazepine reduction in older adults

Introduction: Benzodiazepines (BZD) are potentially inappropriate for older adults, yet their use persists. Patients and providers may hesitate to discontinue BZDs due to concerns for withdrawal or relapse. We reviewed the literature for BZD reduction protocols to examine common elements, safety and efficacy. A framework is proposed for clinicians to address BZD reduction challenges. Areas covered: Following a systematic literature review, this analysis included 28 studies of older out-patients tapering chronic BZDs. Populations included insomnia, depression and anxiety. Protocols included taper alone (32%), taper plus cognitive behavioral therapy (32%) and taper plus medication substitution (36%). Success rates were favorable for all modalities (mean 60%, median 67%, range 25 – 85%) and independent of dose or duration of use. Common schedules included a 25% dose reduction over 1 – 2 weeks until drug-free. Withdrawal symptoms included mainly mild psychological and somatic concerns. No serious safety events were reported. Expert opinion: BZD reduction protocols among older adults are feasible and successful. Given unique cognitive and functional abilities and comorbidities of older adults, a patient-centered approach to reduction is needed. Our framework guides clinicians in planning and persisting with BZD reduction, while our checklist addresses tailored tapers. Monitoring and support is emphasized, and taper modifications are proposed for struggling patients.

[1]  S. Ettner,et al.  Effect of Medicare Part D Benzodiazepine Exclusion on Psychotropic Use in Benzodiazepine Users , 2012, Journal of the American Geriatrics Society.

[2]  S. Greenberg.  American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2012, Journal of the American Geriatrics Society.

[3]  C. Campanelli.  American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2012 .

[4]  V. Jørgensen.  Benzodiazepine reduction in general practice. Are the elderly neglected? , 2012, Journal of affective disorders.

[5]  J. Dyas,et al.  General practitioners' preferences for managing insomnia and opportunities for reducing hypnotic prescribing. , 2010, Journal of evaluation in clinical practice.

[6]  R. Freire,et al.  Tapering Clonazepam in Patients With Panic Disorder After at Least 3 Years of Treatment , 2010, Journal of clinical psychopharmacology.

[7]  K. Rickels,et al.  Physician Withdrawal Checklist (PWC-20) , 2008, Journal of clinical psychopharmacology.

[8]  F. Zitman,et al.  The role of craving in relapse after discontinuation of long-term benzodiazepine use. , 2007, The Journal of clinical psychiatry.

[9]  J. Coyne,et al.  Older primary care patients' willingness to consider discontinuation of chronic benzodiazepines. , 2007, General hospital psychiatry.

[10]  P. Knipschild,et al.  Is melatonin helpful in stopping the long-term use of hypnotics? A discontinuation trial , 2007, Pharmacy World & Science.

[11]  J. Byles,et al.  A Quality Use of Medicines program for general practitioners and older people: a cluster randomised controlled trial , 2007, The Medical journal of Australia.

[12]  J. Coyne,et al.  Older Patient Perspectives on Long-Term Anxiolytic Benzodiazepine Use and Discontinuation: A Qualitative Study , 2007, Journal of General Internal Medicine.

[13]  J. Coyne,et al.  Physicians’ Perspectives on Prescribing Benzodiazepines for Older Adults: A Qualitative Study , 2007, Journal of General Internal Medicine.

[14]  J. Llobera,et al.  Withdrawal from long-term benzodiazepine use: randomised trial in family practice. , 2006, The British journal of general practice : the journal of the Royal College of General Practitioners.

[15]  M. Nakao,et al.  Clinical application of paroxetine for tapering benzodiazepine use in non‐major‐depressive outpatients visiting an internal medicine clinic , 2006, Psychiatry and clinical neurosciences.

[16]  C. Morin,et al.  Benzodiazepine discontinuation among adults with GAD: A randomized trial of cognitive-behavioral therapy. , 2006, Journal of consulting and clinical psychology.

[17]  F. Zitman,et al.  Predictors of Long-Term Benzodiazepine Abstinence in Participants of a Randomized Controlled Benzodiazepine Withdrawal Program , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[18]  F. Zitman,et al.  The absence of benzodiazepine craving in a general practice benzodiazepine discontinuation trial. , 2006, Addictive behaviors.

[19]  C. Morin,et al.  Self-efficacy and compliance with benzodiazepine taper in older adults with chronic insomnia. , 2005, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[20]  G. Chouinard.  Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. , 2004, The Journal of clinical psychiatry.

[21]  C. Morin,et al.  Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. , 2004, The American journal of psychiatry.

[22]  C. Morin,et al.  Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[23]  S. Iliffe,et al.  Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life , 2003, Psychological Medicine.

[24]  F. Zitman,et al.  Development and psychometric evaluation of the Benzodiazepine Craving Questionnaire. , 2003, Addiction.

[25]  F. Zitman,et al.  Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. , 2003, The British journal of psychiatry : the journal of mental science.

[26]  Janet E Hux,et al.  Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[27]  F. Zitman,et al.  The Relevance of Psychiatric and Somatic Comorbidity in Depressed Chronic Benzodiazepine Users , 2002, Psychotherapy and Psychosomatics.

[28]  F. Zitman,et al.  The long-term outcome of a benzodiazepine discontinuation programme in depressed outpatients. , 2002, Journal of affective disorders.

[29]  F. Zitman,et al.  The Benzodiazepine Withdrawal Symptom Questionnaire: psychometric evaluation during a discontinuation program in depressed chronic benzodiazepine users in general practice. , 2002, Addiction.

[30]  F. Zitman,et al.  Chronic benzodiazepine use in general practice patients with depression: an evaluation of controlled treatment and taper-off: report on behalf of the Dutch Chronic Benzodiazepine Working Group. , 2001, The British journal of psychiatry : the journal of mental science.

[31]  H. Möller,et al.  Effectiveness and safety of benzodiazepines. , 1999, Journal of clinical psychopharmacology.

[32]  N. Zisapel,et al.  Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach. , 1999, Archives of internal medicine.

[33]  F. Zitman,et al.  Scalability, reliability, and validity of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users. , 1999, Comprehensive psychiatry.

[34]  B. Geiselmann,et al.  Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions , 1998, Psychological Medicine.

[35]  K. Rickels,et al.  The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients , 1998, Psychological Medicine.

[36]  Randomized Trial of Cognitive‐Behavioral Therapy , 1998 .

[37]  D. Greenblatt,et al.  Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome , 1995, Psychopharmacology.

[38]  D. Strogatz,et al.  Impact of regulation on benzodiazepine prescribing to a low income elderly population, New York State. , 1994, Journal of clinical epidemiology.

[39]  D. Greenblatt,et al.  Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper. , 1990, Archives of general psychiatry.

[40]  D. L. Udelman,et al.  Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy. , 1990, The Journal of clinical psychiatry.

[41]  P. Tyrer,et al.  The Benzodiazepine Withdrawal Symptom Questionnaire. , 1990, Journal of affective disorders.

[42]  P. Williams,et al.  Long term use of benzodiazepines: the views of patients. , 1990, The British journal of general practice : the journal of the Royal College of General Practitioners.

[43]  M. Holm.  One year follow-up of users of benzodiazepines in general practice. , 1990, Danish medical bulletin.

[44]  G. Dunbar,et al.  Patterns of Benzodiazepine use in Great Britain as Measured by a General Population Survey , 1989, British Journal of Psychiatry.

[45]  E. Sellers,et al.  A Clinical Scale to Assess Benzodiazepine Withdrawal , 1989, Journal of clinical psychopharmacology.

[46]  K. Rickels,et al.  Benzodiazepine dependence and withdrawal in elderly patients. , 1989, The American journal of psychiatry.

[47]  C. Naranjo,et al.  Withdrawal reaction after long-term therapeutic use of benzodiazepines , 1987 .

[48]  H. Pinsker,et al.  Use of Benzodiazepines in Primary‐care Geriatric Patients , 1984, Journal of the American Geriatrics Society.

[49]  P. Tyrer,et al.  GRADUAL WITHDRAWAL OF DIAZEPAM AFTER LONG-TERM THERAPY , 1983, The Lancet.

[50]  J. Mucklow,et al.  Benzodiazepine withdrawal in general practice. , 1982, The Journal of the Royal College of General Practitioners.

[51]  M. Åsberg,et al.  A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALE , 1978, Acta psychiatrica Scandinavica. Supplementum.

[52]  A. Bond,et al.  Physiological and psychological measures in anxious patients , 1974, Psychological Medicine.

[53]  C. Morin,et al.  Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse. , 2005, Behaviour research and therapy.

[54]  D. Greenblatt,et al.  Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome , 1999, Psychopharmacology.

[55]  L. Covi,et al.  The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. , 1974, Behavioral science.